{"text": ["Analyst", "Report:", "Novartis", "AG"], "created_at": "2020-10-27 23:54:25"}
{"text": ["Novartis", "Earnings", "Top,", "Sales", "Miss;", "NVS", "Stock", "Falls"], "created_at": "2020-10-27 20:29:52"}
{"text": ["Analyst", "Report:", "Novartis", "AG"], "created_at": "2020-10-27 18:11:37"}
{"text": ["Novartis'", "(NVS)", "Q3", "Earnings", "Surpass", "Estimates,", "Sales", "Miss"], "created_at": "2020-10-27 14:49:02"}
{"text": ["Novartis:", "Q3", "Earnings", "Insights"], "created_at": "2020-10-27 11:59:56"}
{"text": ["Novartis", "upbeat", "as", "drugmakers", "see", "hospitals", "coping", "with", "COVID"], "created_at": "2020-10-27 06:11:10"}
{"text": ["Novartis", "delivers", "solid", "Q3", "performance", "with", "11%", "core", "operating", "income", "growth,", "net", "sales", "in", "line", "with", "prior", "year,", "strong", "pipeline", "progression.", "Upgrades", "full", "year", "core", "operating", "income", "guidance."], "created_at": "2020-10-27 06:00:00"}
